Matthew O'Brien Joins Piper Jaffray Medical Technology Investment Research Team

12/23/2014 | 01:27:56 PM

MINNEAPOLIS--(BUSINESS WIRE)--Dec. 23, 2014-- Piper Jaffray (NYSE:PJC) is pleased to announce the hiring of Matthew O’Brien as a principal and senior research analyst. O’Brien will be based in the firm’s Chicago office, focused on the orthopaedics and spine space as part of the medical technology equity research team.

“Piper Jaffray has a longstanding reputation in the medical technology arena,” said Michael Cox, director of equity research at Piper Jaffray. “Our medtech leadership reflects an ongoing commitment to providing relevant and timely insights to clients. Matt will be integral in contributing to this effort.”

Previously, O’Brien spent 10 years at William Blair & Company, LLC, where he was most recently a senior analyst leading coverage of orthopaedics, vision care and heart failure companies. Prior to that, he worked in investment banking and financial advisory at Duff & Phelps, LLC. O’Brien holds a bachelor’s degree in finance from DePaul University and a Master of Business Administration degree from the University of Chicago.

Piper Jaffray has a total of 29 senior research analysts located in Minneapolis, New York, San Francisco and Chicago. The firm provides coverage on approximately 584 companies in the following key sectors: business & financial services; clean technology & industrial growth; consumer; healthcare; and technology, media & telecommunications.

About Piper Jaffray
Piper Jaffray Companies (NYSE: PJC) is an investment bank and asset management firm headquartered in Minneapolis with offices across the U.S. and in London, Hong Kong* and Zurich. Securities brokerage and investment banking services are offered in the United States through Piper Jaffray & Co., member NYSE and SIPC, and in Europe through Piper Jaffray Ltd., authorized and regulated by the Financial Conduct Authority. Asset management products and services are offered through three separate investment advisory affiliates registered with the U.S. Securities and Exchange Commission: Advisory Research Inc., Piper Jaffray Investment Management LLC and PJC Capital Partners LLC.

* License pending

Follow Piper Jaffray: LinkedIn | Facebook | Twitter

© 2014 Piper Jaffray Companies, 800 Nicollet Mall, Suite 1000, Minneapolis, Minnesota 55402-7020

Source: Piper Jaffray Companies

Piper Jaffray & Co.
Pamela Steensland, 612-303-8184